These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
190 related articles for article (PubMed ID: 36690660)
1. Catechol-O-methyl transferase suppresses cell invasion and interplays with MET signaling in estrogen dependent breast cancer. Janacova L; Stenckova M; Lapcik P; Hrachovinova S; Bouchalova P; Potesil D; Hrstka R; Müller P; Bouchal P Sci Rep; 2023 Jan; 13(1):1285. PubMed ID: 36690660 [TBL] [Abstract][Full Text] [Related]
2. The impact of Catechol-O-methyl transferase knockdown on the cell proliferation of hormone-responsive cancers. Tolba MF; Omar HA; Hersi F; Nunes ACF; Noreddin AM Mol Cell Endocrinol; 2019 May; 488():79-88. PubMed ID: 30904591 [TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyltransferase (COMT)-mediated metabolism of catechol estrogens: comparison of wild-type and variant COMT isoforms. Dawling S; Roodi N; Mernaugh RL; Wang X; Parl FF Cancer Res; 2001 Sep; 61(18):6716-22. PubMed ID: 11559542 [TBL] [Abstract][Full Text] [Related]
4. The Val158Met polymorphism in COMT gene and cancer risk: role of endogenous and exogenous catechols. Sak K Drug Metab Rev; 2017 Feb; 49(1):56-83. PubMed ID: 27826992 [TBL] [Abstract][Full Text] [Related]
5. Soy isoflavones decrease the catechol-O-methyltransferase-mediated inactivation of 4-hydroxyestradiol in cultured MCF-7 cells. Lehmann L; Jiang L; Wagner J Carcinogenesis; 2008 Feb; 29(2):363-70. PubMed ID: 18192686 [TBL] [Abstract][Full Text] [Related]
6. Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase. Li Y; Yao J; Chang M; Nikolic D; Yu L; Yager JD; Mesecar AD; van Breemen RB; Bolton JL Chem Res Toxicol; 2004 Apr; 17(4):512-20. PubMed ID: 15089093 [TBL] [Abstract][Full Text] [Related]
7. The effects of catechol-O-methyltransferase inhibition on estrogen metabolite and oxidative DNA damage levels in estradiol-treated MCF-7 cells. Lavigne JA; Goodman JE; Fonong T; Odwin S; He P; Roberts DW; Yager JD Cancer Res; 2001 Oct; 61(20):7488-94. PubMed ID: 11606384 [TBL] [Abstract][Full Text] [Related]
8. Assessment of cellular estrogenic activity based on estrogen receptor-mediated reduction of soluble-form catechol-O-methyltransferase (COMT) expression in an ELISA-based system. Ho PW; Tse ZH; Liu HF; Lu S; Ho JW; Kung MH; Ramsden DB; Ho SL PLoS One; 2013; 8(9):e74065. PubMed ID: 24040167 [TBL] [Abstract][Full Text] [Related]
9. Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage. van Duursen MB; Sanderson JT; de Jong PC; Kraaij M; van den Berg M Toxicol Sci; 2004 Oct; 81(2):316-24. PubMed ID: 15254334 [TBL] [Abstract][Full Text] [Related]
10. Nordihydroguaiaretic Acid as a Novel Substrate and Inhibitor of Catechol Kim JH; Lee J; Jeong H; Bang MS; Jeong JH; Chang M Molecules; 2021 Apr; 26(7):. PubMed ID: 33916785 [TBL] [Abstract][Full Text] [Related]
11. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk. Ho PW; Garner CE; Ho JW; Leung KC; Chu AC; Kwok KH; Kung MH; Burka LT; Ramsden DB; Ho SL Curr Drug Metab; 2008 May; 9(4):304-9. PubMed ID: 18473748 [TBL] [Abstract][Full Text] [Related]
12. Characterization of human soluble high and low activity catechol-O-methyltransferase catalyzed catechol estrogen methylation. Goodman JE; Jensen LT; He P; Yager JD Pharmacogenetics; 2002 Oct; 12(7):517-28. PubMed ID: 12360102 [TBL] [Abstract][Full Text] [Related]
13. Catechol estrogen 4-hydroxyequilenin is a substrate and an inhibitor of catechol-O-methyltransferase. Yao J; Li Y; Chang M; Wu H; Yang X; Goodman JE; Liu X; Liu H; Mesecar AD; Van Breemen RB; Yager JD; Bolton JL Chem Res Toxicol; 2003 May; 16(5):668-75. PubMed ID: 12755597 [TBL] [Abstract][Full Text] [Related]
14. Catecholestrogens induce oxidative stress and malignant transformation in human endometrial glandular cells: protective effect of catechol-O-methyltransferase. Salama SA; Kamel M; Awad M; Nasser AH; Al-Hendy A; Botting S; Arrastia C Int J Cancer; 2008 Sep; 123(6):1246-54. PubMed ID: 18566989 [TBL] [Abstract][Full Text] [Related]
15. Multiple promoters of catechol-O-methyltransferase gene are selectively inactivated by CpG hypermethylation in endometrial cancer. Sasaki M; Kaneuchi M; Sakuragi N; Dahiya R Cancer Res; 2003 Jun; 63(12):3101-6. PubMed ID: 12810635 [TBL] [Abstract][Full Text] [Related]
16. Cholesterol biosynthesis pathway as a novel mechanism of resistance to estrogen deprivation in estrogen receptor-positive breast cancer. Simigdala N; Gao Q; Pancholi S; Roberg-Larsen H; Zvelebil M; Ribas R; Folkerd E; Thompson A; Bhamra A; Dowsett M; Martin LA Breast Cancer Res; 2016 Jun; 18(1):58. PubMed ID: 27246191 [TBL] [Abstract][Full Text] [Related]
17. Expression of estrogenicity genes in a lineage cell culture model of human breast cancer progression. Fu J; Weise AM; Falany JL; Falany CN; Thibodeau BJ; Miller FR; Kocarek TA; Runge-Morris M Breast Cancer Res Treat; 2010 Feb; 120(1):35-45. PubMed ID: 19308726 [TBL] [Abstract][Full Text] [Related]
18. Characterization and implications of estrogenic down-regulation of human catechol-O-methyltransferase gene transcription. Xie T; Ho SL; Ramsden D Mol Pharmacol; 1999 Jul; 56(1):31-8. PubMed ID: 10385681 [TBL] [Abstract][Full Text] [Related]
19. Expression and cyclic variations of catechol-O-methyl transferase in human endometrial stroma. Salih SM; Salama SA; Fadl AA; Nagamani M; Al-Hendy A Fertil Steril; 2008 Sep; 90(3):789-97. PubMed ID: 17418156 [TBL] [Abstract][Full Text] [Related]